Martek Offering Nets $81 Million

Martek Biosciences has received $81.4 million in net proceeds from its recent stock offering, which it plans to use for capital expenditures, working capital and general corporate purposes. The Columbia maker of nutritional oils from microalgae used in infant formula closed Wednesday on its sale of approximately 1.7 million shares of common stock at $49.10 per share. The sale included approximately 1.5 million shares of common stock and the underwriter's option to purchase 229,000 additional common shares to cover over-allotments.

Baltimore Business Journal (http://www.bizjournals.com/baltimore/stories/2005/01/24/daily24.html)